Drug application
DIUPRES-250 (CHLOROTHIAZIDE, RESERPINE)
Drugs@FDA NDA 011635 · MERCK
Key facts
| Drug name | DIUPRES-250 |
|---|---|
| Active ingredients | CHLOROTHIAZIDE, RESERPINE |
| Application type | NDA |
| Application number | 011635 |
| Company | MERCK |
| Dosage forms | TABLET, ORAL |
| Strength | 250MG;0.125MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 4 - New Combination |
| Latest submission status date | Dec 11, 1958 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.